What are carriers actually looking at with diabetes?
Simplified issue life insurance asks a specific set of yes or no questions. For diabetes, the question set is looking at treatment stability, not the fact of the diagnosis. Someone who has had type 2 diabetes for fifteen years, managed with stable oral medication, no recent changes, and no significant complications, answers the diabetes section of most simplified issue applications very differently from someone who was recently diagnosed and has just had their insulin adjusted.
Three factors carry the most weight in the simplified issue assessment:
Blood sugar control. Carriers look at recent control rather than the full history of the condition. Consistently controlled blood sugar over the most recent period, typically the last several months, signals a well-managed condition. Carriers differ on what thresholds they use, and the precise number matters less than the trend of stability. Controlled and stable is the picture underwriters are looking for.
Medication stability. A prescription that has been unchanged for a sufficient period signals that the treatment is working. A recent insulin change, a new medication, or a dosage adjustment within the last several months can temporarily shift the outcome. That shift is not permanent. Once the new medication has been stable long enough, the picture generally improves. A licensed advisor can identify the right timing before an application goes in.
Age. Age at application matters independently of how diabetes is managed. For applicants under 30, the coverage structure is more restricted regardless of how well the diabetes is controlled. That situation is covered separately in Part 2 of this series.
For most Canadians 30 and over with stable diabetes management and no significant complications, the outcome in the simplified issue market is considerably more accessible than they expect. Both term and permanent coverage are typically available. A licensed advisor familiar with the no-exam market can identify the carriers most likely to assess a specific profile favourably.
Does it matter whether it's Type 1 or Type 2 diabetes?
The type 1 versus type 2 distinction matters less in the simplified issue market than most applicants assume. The question set is looking at the management picture, not the diagnostic label. A type 1 applicant on a stable insulin regimen with well-controlled blood sugar is assessed based on those facts, not on the type 1 label. A type 2 applicant with a recent medication change is assessed on that change regardless of their type designation.
What does create meaningful distinctions in the simplified issue market:
Diagnosis age. Being diagnosed at 39 or under places a separate question in play, particularly if insulin has been adjusted recently. This is the situation covered in Part 3 of this series, the early onset article.
Insulin use generally. The fact of taking insulin is not itself a trigger in the simplified issue market. The question is whether insulin was recently changed or started. Long-term, stable insulin use that hasn't changed is assessed as part of the overall stability picture, not as a separate restriction.
Oral medication only. Applicants managing diabetes with metformin or other oral medications only, with no insulin, and with stable control, typically sit at the most accessible end of the diabetes spectrum in the simplified issue market.
Does a recent medication change affect your application?
A medication change within the recent past, whether an insulin dose adjustment, a switch between medications, or the addition of a new drug, temporarily affects the simplified issue assessment. Both term and permanent coverage typically remain available in this situation, but coverage amounts may be more conservative and some carriers may apply a partial deferral on the non-accidental death benefit.
This is a temporary state, not a permanent one. Once the new medication has been stable for a sufficient period, the picture moves back toward the standard outcome for a well-managed diabetic. The specific timeline varies by carrier. Timing an application to coincide with medication stability can produce a meaningfully better outcome, and a licensed advisor can help identify the right window.
If a medication change happened recently, it is worth knowing approximately when before applying. That timing affects which carriers and products are the right fit. Applying immediately after a change, without understanding how the change affects the assessment, risks locking in a more restricted structure that would resolve with a short wait.
How do diabetes complications change what's available?
Everything in this article applies to diabetes without significant complications. Once complications enter the picture, the outcome shifts substantially and the situation belongs in a different article.
The complications that change the eligibility picture are cardiovascular disease, stroke, neuropathy, nephropathy, retinopathy, peripheral vascular disease, and amputation. Any of these, at any point in history regardless of when they occurred, shifts the outcome to a permanent-only structure with a waiting period and lower coverage amounts. The complication question is assessed independently of the diabetes itself.
If any of these are part of the history, Part 4 of this series covers that situation directly and explains what coverage looks like and why it still has real value.
Is fully underwritten coverage worth asking about with diabetes?
This article has focused on the simplified issue market, which is where most Canadians with diabetes start because it doesn't require a medical exam. For applicants with stable, well-controlled diabetes and no complications, the fully underwritten market is worth asking about as a secondary option.
Some fully underwritten carriers assess well-managed diabetes at standard or near-standard rates, particularly when A1C has been consistently controlled, medication has been stable for a meaningful period, and regular follow-up has been documented. The tradeoff is process: a detailed health questionnaire, possibly blood and urine tests, and a longer approval timeline. For applicants with larger coverage needs where the premium difference is significant, that process may be worth it. timing your application
A licensed advisor can run both paths side by side for a specific profile and identify which is likely to produce the better outcome.
What to Bring to the Conversation
Before speaking with a licensed advisor, know how long the diabetes has been diagnosed, what medications are currently prescribed and how long they have been stable, and whether any complications have ever been diagnosed. That picture is what determines the right carrier and the right product.
Know the monthly premium that is genuinely comfortable to sustain long term. Know the obligations a death would leave behind: a mortgage, dependents, a spouse who relies on income, final expenses. Coverage amount follows from that picture.
For most Canadians in this situation, the conversation produces a better answer than the one they assumed before they started.
This article is for educational purposes only and does not constitute insurance advice. Eligibility, premiums, and coverage terms vary by individual health profile and insurer. Speak with a licensed Canadian insurance advisor before making any coverage decision. Reviewed by a licensed Canadian insurance professional.